Comparison of Uveitis Incidence by Medication in Juvenile Idiopathic Arthritis and Implications for Screening

To determine uveitis incidence in juvenile idiopathic arthritis (JIA) patients treated with disease-modifying antirheumatic drugs (DMARD) medications, and to evaluate uveitis risk-stratification protocols. Retrospective clinical cohort study. Medical records of patients with JIA seen by ophthalmolog...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 2023-03, Vol.247, p.70-78
Main Authors: Bison, Henry S., Janetos, Timothy M., Gao, Hans M., Zhang, David L., Song, Jessica, Bohnsack, Brenda L.
Format: Article
Language:English
Subjects:
Adalimumab - adverse effects
Antirheumatic Agents - adverse effects
Arthritis, Juvenile - complications
Biological Products - adverse effects
Cohort Studies
Etanercept - adverse effects
Humans
Incidence
Methotrexate - therapeutic use
Retrospective Studies
Treatment Outcome
Uveitis - diagnosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine uveitis incidence in juvenile idiopathic arthritis (JIA) patients treated with disease-modifying antirheumatic drugs (DMARD) medications, and to evaluate uveitis risk-stratification protocols. Retrospective clinical cohort study. Medical records of patients with JIA seen by ophthalmology at a single institution from April 2014 to April 2022 and ≥18 months’ follow-up were reviewed. Exclusion criteria included uveitis history prior to study period, Still disease, or
ISSN:0002-9394
1879-1891
DOI:10.1016/j.ajo.2022.11.010